Moderna has been awarded a potential $472M contract modification by the Biomedical Advanced Research and Development Authority to expand late-stage clinical trials of a messenger RNA-based vaccine ...

Moderna has received a six-month, $1.97B contract modification from the U.S. Army to manufacture 100M more doses of the company's messenger RNA vaccine against the novel coronavirus. Army Contracting ...

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, ...

There are several basic types of vaccines being developed to battle COVID. Across the globe, scientists are scrambling to develop multiple vaccines with the goal of stopping the deadly coronavirus in ...

New FDA approval language for COVID-19 vaccines is sowing confusion about which conditions put people at greater risk for severe disease and who can avoid the inconvenience and cost of off-label ...

A Moderna COVID-19 vaccine (brand name: Spikevax) photographed at Borinquen Health Care Center on May 29 in Miami. (Photo illustration by Joe Raedle/Getty Images) The Food and Drug Administration ...